ClinConnect ClinConnect Logo
Search / Trial NCT06614946

Improving Coping to Reduce Suicide Risk Following ED Discharge

Launched by UNIVERSITY OF MICHIGAN · Sep 25, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Emergency Department

ClinConnect Summary

This clinical trial is looking at new ways to help adults who have recently experienced suicidal thoughts or behaviors after leaving the emergency department (ED). The researchers want to see if an electronic safety plan (ESP), which is a personalized guide for staying safe, along with a supportive text messaging program, can help these individuals cope better and reduce their risk of suicide. By testing these tools, they hope to find effective ways to support patients after their ED visit.

To be eligible for this study, participants need to be adults who have either attempted suicide in the last month or have had thoughts of harming themselves in the past week. However, the study will not include individuals who are severely mentally impaired, very aggressive, or who are being admitted to a hospital for more treatment. Participants can expect to engage with the ESP and receive supportive messages on their phones, which will help them manage their feelings and stay safe after their emergency visit. This trial is not yet recruiting participants, but it is an important step toward improving care for people at risk of suicide.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Individuals presenting to an ED with either:
  • 1. actual, interrupted, or aborted attempt in the last 4 weeks
  • 2. suicidal ideation within the last week
  • Exclusion Criteria:
  • Severe cognitive impairment or altered mental status (psychosis, manic state)
  • Severe aggression/agitation,
  • Being admitted or transferred into inpatient care,
  • Patient not owning a cell phone with text messaging capability

About University Of Michigan

The University of Michigan, a leading academic institution renowned for its commitment to advancing healthcare and medical research, serves as a prominent clinical trial sponsor. With a robust infrastructure that supports innovative research initiatives, the university leverages its multidisciplinary expertise to conduct a wide array of clinical trials aimed at improving patient outcomes and advancing medical knowledge. Through its state-of-the-art facilities and collaborative environment, the University of Michigan fosters partnerships between researchers, clinicians, and industry leaders, ensuring the development of cutting-edge therapies and interventions that address pressing health challenges.

Locations

Ann Arbor, Michigan, United States

Patients applied

0 patients applied

Trial Officials

Ewa Czyz, Ph.D.

Principal Investigator

University of Michigan

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported